Crystalline Management’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

Crystalline Management’s Portfolio FUSN Stock Details FUSN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-11,207	Closed	-$239K	–	116
2024 Q1	$239K	Buy	+11,207	New	+$134K	0.31%	50

Crystalline Management's FUSN Position: Q2 2024 in Review

Crystalline Management sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q2 2024, closing a stake of 11,207 shares — an estimated $239K sold.

Crystalline Management first reported a position in FUSN in Q1 2024 and held it in 1 quarter. The position peaked at $239K in Q1 2024. 0 funds tracked by Wall St. Rank hold FUSN as of Q2 2024.

Crystalline Management reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q2 2024 after selling out during the quarter.
Crystalline Management sold 11,207 Fusion Pharmaceuticals Inc. Common Shares shares in Q2 2024, an estimated $239K.
Crystalline Management first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q1 2024 and held it in 1 quarter.
Crystalline Management's Fusion Pharmaceuticals Inc. Common Shares position peaked at $239K in Q1 2024.
0 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q2 2024.

Based on Crystalline Management's 13F filing for Q2 2024, filed 8 Aug 2024.